SBRA Stock Forecast & Price Target

Sabra Health Care REIT is benefiting from a clearer growth trajectory as it re-tenants all 26 Avamere properties at about a 30% premium to trailing cash rent, adds more than $9 million of incremental annual cash NOI from other portfolio actions, and expects the full transition to support roughly $53 million of annualized cash rent. Its fundamentals are also improving through stronger senior housing exposure, with SHOP set to be 40% of gross assets by FYE26, same-store SHOP NOI up 14.4% in 1Q26, and $277 million of SHOP and SNF investments closed at a 7.9% initial cash yield. Balance-sheet and earnings quality are improving as well, with Net Debt-to-EBITDA at 4.8x, RCA resolved through a $200 million repayment that reduced risk, and 2026 normalized AFFO per share guided to $1.59-$1.61.

Sabra Health Care REIT is weighed down by tenant operating fragility, reimbursement dependence, and regulatory exposure, all of which could impair operators’ ability to cover rent or debt payments if Medicaid, Medicare, or other payers reduce rates. Its financial profile also faces pressure from capital and leverage risk, with the company relying on external funding while carrying debt that could hinder obligations, and management’s raised FY26 G&A expense guidance to $61 million adds further dilution to 2026 FFO expectations. In addition, the $100 million loss on debt extinguishment and a $200 million mortgage repayment below par highlight weaker credit conditions in behavioral health, while higher competition could make acquisitions less accretive and constrain growth.